Rockwell Medical, Inc. (RMTI) financial statements and ratios from SEC XBRL: revenue $69.26M (TTM), net margin -7.7%, revenue growth -31.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $69.26M |
| Net Margin | -7.7% |
| Revenue Growth (YoY) | -31.8% |
| EPS Growth (YoY) | 400.0% |
| FCF Growth (YoY) | -137.6% |
| Price / Book | 8.81 |
| Price / Sales | 4.63 |
| FCF Yield | -3.0% |
| Altman Z-Score | 1.05 (distress) |
| Piotroski F-Score | 2/9 |
| Sector P/E (Healthcare) | 21.7 |
RMTI overview · RMTI earnings · RMTI KPIs · RMTI investor relations · RMTI ownership · RMTI peers · RMTI filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.